Moneycontrol PRO
you are here: HomeNewsIndia

Project Platina: Maharashtra to launch 'world's largest' plasma therapy trial for COVID-19 patients

Maharashtra Chief Minister Uddhav Thackeray has approved Rs 16.65 crore from the Chief Minister’s Relief Fund for the project.

June 29, 2020 / 12:10 PM IST

The Maharashtra government is set to launch Project Platina, a plasma therapy trial on COVID-19 patients, as infections continue to rise in the western state, reported News18.

The trial, reportedly the “world's largest”, is set to start at 12.30 pm on June 29.

In the absence of a cure for COVID-19, the respiratory illness caused by the coronavirus, the convalescent plasma therapy, an experimental treatment, is the next best bet for severe cases,  the report said.

Twenty-one centres have been picked for the trial, including 17 medical colleges under the department of medical education and drugs, the government of Maharashtra and four BMC medical colleges in Mumbai. Initially, the project will launched in 13 centres, the report said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Critical patients will receive two doses of 200 ml of plasma recovered from COVID-19 patients. Plasma, which is the liquid part of the blood, will have antibodies to the coronavirus, thereby fight the infection, the report said.

The treatment will be free of cost and there are enough donors for the trial.

Also read | 2 km rule: Mumbai Police to take strict action against violators of COVID-19 lockdown guidelines

Project Platina will be the “world’s largest trial and hence will give robust data regarding the role of convalescent plasma in the treatment of COVID-19 patients”, the government said.

Maharashtra Chief Minister Uddhav Thackeray has approved Rs 16.65 crore from the Chief Minister’s Relief Fund for the project.

Follow our full coverage on COVID-19 here.
Moneycontrol News
first published: Jun 29, 2020 11:12 am